Amlodipine Besylate

Product NDC: 53808-0653
11-digit product format: 538080653
Labeler code: 53808
Product ID: 53808-0653_24efe210-73f3-446c-a8d3-88baa1508702
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: amlodipine besylate
Dosage form: TABLET
Route: ORAL
Labeler: State of Florida DOH Central Pharmacy
Application: ANDA076418
Marketing category: ANDA
Marketing start: 2009-07-01
Marketing end: 0000-00-00
Substance: AMLODIPINE BESYLATE
Active strength: 3 mg/1
Pharmacologic classes: Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	53808-0653		I	Inactivated by FDA		2026-10-05
excluded package	package	53808-0653	53808-0653-1	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53808-0653-1	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53808-0653-1	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53808-0653-1	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53808-0653-1	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53808-0653-1	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53808-0653-1	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53808-0653-1	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53808-0653-1	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53808-0653-1	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	53808-0653-1	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	53808-0653-1	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	53808-0653-1	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	53808-0653-1	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	53808-0653-1	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	53808-0653-1	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	53808-0653-1	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	53808-0653-1	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	53808-0653-1	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	53808-0653-1	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53808-0653-1	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53808-0653-1	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	53808-0653-1	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A076418-001	AMLODIPINE BESYLATE	AMLODIPINE BESYLATE	EQ 2.5MG BASE	TABLET / ORAL	2005-10-03
A076418-002	AMLODIPINE BESYLATE	AMLODIPINE BESYLATE	EQ 5MG BASE	TABLET / ORAL	2005-10-03
A076418-003	AMLODIPINE BESYLATE	AMLODIPINE BESYLATE	EQ 10MG BASE	TABLET / ORAL	2005-10-03

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2019-12-14 00:12 UTC	2019-12	A076418-003	AMLODIPINE BESYLATE	EQ 10MG BASE	TABLET / ORAL	AB	2005-10-03	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A076418-001	AMLODIPINE BESYLATE	EQ 2.5MG BASE	TABLET / ORAL	AB	2005-10-03	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A076418-002	AMLODIPINE BESYLATE	EQ 5MG BASE	TABLET / ORAL	AB	2005-10-03	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A076418-003	AMLODIPINE BESYLATE	EQ 10MG BASE	TABLET / ORAL	AB	2005-10-03	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A076418-001	AMLODIPINE BESYLATE	EQ 2.5MG BASE	TABLET / ORAL	AB	2005-10-03	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A076418-002	AMLODIPINE BESYLATE	EQ 5MG BASE	TABLET / ORAL	AB	2005-10-03	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A076418-003	AMLODIPINE BESYLATE	EQ 10MG BASE	TABLET / ORAL	AB	2005-10-03	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A076418-001	AMLODIPINE BESYLATE	EQ 2.5MG BASE	TABLET / ORAL		2005-10-03	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A076418-002	AMLODIPINE BESYLATE	EQ 5MG BASE	TABLET / ORAL		2005-10-03	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A076418-003	AMLODIPINE BESYLATE	EQ 10MG BASE	TABLET / ORAL		2005-10-03	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A076418-001	AMLODIPINE BESYLATE	EQ 2.5MG BASE	TABLET / ORAL		2005-10-03	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A076418-002	AMLODIPINE BESYLATE	EQ 5MG BASE	TABLET / ORAL		2005-10-03	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A076418-003	AMLODIPINE BESYLATE	EQ 10MG BASE	TABLET / ORAL		2005-10-03	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A076418-001	AMLODIPINE BESYLATE	EQ 2.5MG BASE	TABLET / ORAL		2005-10-03	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A076418-002	AMLODIPINE BESYLATE	EQ 5MG BASE	TABLET / ORAL		2005-10-03	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A076418-003	AMLODIPINE BESYLATE	EQ 10MG BASE	TABLET / ORAL		2005-10-03	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A076418-001	AMLODIPINE BESYLATE	EQ 2.5MG BASE	TABLET / ORAL		2005-10-03	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A076418-002	AMLODIPINE BESYLATE	EQ 5MG BASE	TABLET / ORAL		2005-10-03	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A076418-003	AMLODIPINE BESYLATE	EQ 10MG BASE	TABLET / ORAL		2005-10-03	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A076418-001	AMLODIPINE BESYLATE	EQ 2.5MG BASE	TABLET / ORAL		2005-10-03	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A076418-002	AMLODIPINE BESYLATE	EQ 5MG BASE	TABLET / ORAL		2005-10-03	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A076418-003	AMLODIPINE BESYLATE	EQ 10MG BASE	TABLET / ORAL		2005-10-03	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A076418-001	AMLODIPINE BESYLATE	EQ 2.5MG BASE	TABLET / ORAL		2005-10-03	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A076418-002	AMLODIPINE BESYLATE	EQ 5MG BASE	TABLET / ORAL		2005-10-03	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A076418-003	AMLODIPINE BESYLATE	EQ 10MG BASE	TABLET / ORAL		2005-10-03	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A076418-001	AMLODIPINE BESYLATE	EQ 2.5MG BASE	TABLET / ORAL		2005-10-03	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A076418-002	AMLODIPINE BESYLATE	EQ 5MG BASE	TABLET / ORAL		2005-10-03	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A076418-003	AMLODIPINE BESYLATE	EQ 10MG BASE	TABLET / ORAL		2005-10-03	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A076418-001	AMLODIPINE BESYLATE	EQ 2.5MG BASE	TABLET / ORAL		2005-10-03	`053a50430f4f…`
2023-05-13 08:27 UTC	2023-05	A076418-002	AMLODIPINE BESYLATE	EQ 5MG BASE	TABLET / ORAL		2005-10-03	`053a50430f4f…`
2023-05-13 08:27 UTC	2023-05	A076418-003	AMLODIPINE BESYLATE	EQ 10MG BASE	TABLET / ORAL		2005-10-03	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A076418-001	AMLODIPINE BESYLATE	EQ 2.5MG BASE	TABLET / ORAL		2005-10-03	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	A076418-002	AMLODIPINE BESYLATE	EQ 5MG BASE	TABLET / ORAL		2005-10-03	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	A076418-003	AMLODIPINE BESYLATE	EQ 10MG BASE	TABLET / ORAL		2005-10-03	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A076418-001	AMLODIPINE BESYLATE	EQ 2.5MG BASE	TABLET / ORAL		2005-10-03	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A076418-002	AMLODIPINE BESYLATE	EQ 5MG BASE	TABLET / ORAL		2005-10-03	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A076418-003	AMLODIPINE BESYLATE	EQ 10MG BASE	TABLET / ORAL		2005-10-03	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A076418-001	AMLODIPINE BESYLATE	EQ 2.5MG BASE	TABLET / ORAL		2005-10-03	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	A076418-002	AMLODIPINE BESYLATE	EQ 5MG BASE	TABLET / ORAL		2005-10-03	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	A076418-003	AMLODIPINE BESYLATE	EQ 10MG BASE	TABLET / ORAL		2005-10-03	`f41ea6bd6efb…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A076418-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076418-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076418-003	AB	1	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	A076418-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A076418-002	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A076418-003	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A076418-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A076418-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A076418-003	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A076418-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A076418-002	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A076418-003	AB	1	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fa898d56-9495-d6f0-309b-68a5d8e3914a	Product name	4	20260305
c19ec24d-2c40-4b8d-7c20-500ffa3660a1	Product name	3	20260303
b15e9aa6-d523-ca97-480e-570e0543a342	Product name	4	20251024
265792b3-b999-c010-7364-a7db20b9d4d9	Product name	5	20250515
14c2c15b-f823-4ada-a40e-a440544294dc	Product name	1	20221207
a72887ef-d675-499f-af4b-78688f6855cd	Product name	1	20191002
a4484670-2869-6416-f6ff-03b1b3cbd1b0	Product name	2	20190415
4a27501f-a987-48a5-99b4-e983d4744d76	Product name	7	20181211
18600d07-613d-bf9c-2711-fe40c06f3393	Product name	5	20180703
bded1554-44de-900a-5297-403365d6d4b2	Product name	3	20170110
1f1c6e4b-bbad-4649-afd1-7a1d671db4b1	Product name	1	20150316
63ab5fbf-2a6b-c41d-051a-39e845d718b1	Product name	1	20140508
7613b1a5-acb6-4e5e-6048-c44deeeb1212	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
53808-0653-1	2021-01-29	C162847	48780-1	956f9ecf-df02-621f-e053-dbdaa90a74ad	a10fa641-ac6b-466d-bcba-31c678a74be8
53808-0653-1	2019-10-21	C162847	48780-1	956f9ecf-df02-621f-e053-dbdaa90a74ad	a10fa641-ac6b-466d-bcba-31c678a74be8

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
53808-0653-1	Amlodipine Besylate	30 in 1 BLISTER PACK	TABLET	30		4

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
AMLODIPINE BESYLATE	ACTIVE INGREDIENT	864V2Q084H	AMLODIPINE BESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
AMLODIPINE	ACTIVE MOIETY	1J444QC288	AMLODIPINE BESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	INACTIVE INGREDIENT	L11K75P92J	AMLODIPINE BESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	AMLODIPINE BESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	AMLODIPINE BESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	AMLODIPINE BESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53808-0653	AMLODIPINE BESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	4	Legacy NDC, 1 package rows	20100824_a10fa641-ac6b-466d-bcba-31c678a74be8.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
864V2Q084H	AMLODIPINE BESYLATE	111470-99-6	AMLODIPINE BESYLATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
308136	amLODIPine besylate 2.5 MG Oral Tablet	PSN	a10fa641-ac6b-466d-bcba-31c678a74be8	4
197361	amLODIPine besylate 5 MG Oral Tablet	PSN	a10fa641-ac6b-466d-bcba-31c678a74be8	4
308136	amlodipine 2.5 MG Oral Tablet	SCD	a10fa641-ac6b-466d-bcba-31c678a74be8	4
197361	amlodipine 5 MG Oral Tablet	SCD	a10fa641-ac6b-466d-bcba-31c678a74be8	4
308136	amlodipine (as amlodipine besylate) 2.5 MG Oral Tablet	SY	a10fa641-ac6b-466d-bcba-31c678a74be8	4
197361	amlodipine (as amlodipine besylate) 5 MG Oral Tablet	SY	a10fa641-ac6b-466d-bcba-31c678a74be8	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
53808-0653-1	53808065301	30 in 1 BLISTER PACK	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Amlodipine Besylate - State of Florida DOH Central Pharmacy	State of Florida DOH Central Pharmacy	2010-08-12	HUMAN PRESCRIPTION DRUG LABEL	4